Abstract
Small intestinal infections are extremely common worldwide. They may be bacterial, viral, or parasitic in etiology. Most are foodborne or waterborne, with specific etiologies differing by region and with diverse pathophysiologies. Very young, very old, and immune-deficient individuals are the most vulnerable to morbidity or mortality from small intestinal infections. There have been significant advances in diagnostic sophistication with the development and early application of molecular diagnostic assays, though these tests have not become mainstream. The lack of rapid diagnoses combined with the self-limited nature of small intestinal infections has hampered the development of specific and effective treatments other than oral rehydration. Antibiotics are not indicated in the absence of an etiologic diagnosis, and not at all in the case of some infections.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Guerrant RL, Kosek M, Lima AAM, Lorntz B, Guyatt HL. Updating the DALYs for diarrhoeal disease. Trends Parasitol. 2002;18(5):191–3.
Checkley W, Buckley G, Gilman RH, et al. Multi-country analysis of the effects of diarrhoea on childhood stunting. Int J Epidemiol. 2008;37(4):816–30. doi:10.1093/ije/dyn099.
CDC National Health report: leading causes of morbidity and mortality and associated behavioral risk and protective factors—United States, 2005–2013. http://www.cdc.gov/mmwr/preview/mmwrhtml/su6304a2.htm. Accessed 6 Jan 2016.
Network S, Sites US. Morbidity and Mortality Weekly Report ( MMWR ) Incidence and trends of infection with pathogens transmitted commonly through food—foodborne diseases active. 2015;914:1–7.
Preliminary incidence and trends of infection with pathogens transmitted commonly through food—foodborne diseases active surveillance network, 10 U.S. Sites, 2006–2014. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6418a4.htm. Accessed 7 Jan 2016. Good review on trends in foodborne illnesses.
CDC vital signs 2015. http://www.cdc.gov/vitalsigns/pdf/2015-11-vitalsigns.pdf. Accessed 7 Jan 2016.
Kelly C. Food poisoning. Chapter 111 Sleisenger and Fordtran’s gastrointestinal and liver disease: pathophysiology/diagnosis/management. 10th edition.
Popoff MR. Multifaceted interactions of bacterial toxins with the gastrointestinal mucosa. Future Microbiol. 2011;6(7):763–97. doi:10.2217/fmb.11.58.
Dasti JI, Tareen AM, Lugert R, Zautner AE, Gross U. Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms. Int J Med Microbiol. 2010;300(4):205–11. doi:10.1016/j.ijmm.2009.07.002.
de Jong HK, Parry CM, van der Poll T, Wiersinga WJ. Host-pathogen interaction in invasive Salmonellosis. PLoS Pathog. 2012;8(10), e1002933. doi:10.1371/journal.ppat.1002933.
Yuki N, Hartung H-P. Guillain-Barré syndrome. N Engl J Med. 2012;366(24):2294–304. doi:10.1056/NEJMra1114525.
Scallan E, Griffin PM, Angulo FJ, Tauxe RV, Hoekstra RM. Foodborne illness acquired in the United States—unspecified agents. Emerg Infect Dis. 2011;17(1):16–22. doi:10.3201/eid1701.091101p2. Very good review on epidemiology of foodborne illnesses.
Slutsker L, Ries AA, Greene KD, Wells JG, Hutwagner L, Griffin PM. Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features. Ann Intern Med. 1997;126(7):505–513. http://www.ncbi.nlm.nih.gov/pubmed/9092315. Accessed 7 Jan 2016.
Norovirus | U.S. Trends and Outbreaks | CDC. http://www.cdc.gov/norovirus/trends-outbreaks.html. Accessed 7 Jan 2016.
Cortes JE, Curns AT, Tate JE, et al. Rotavirus vaccine and health care utilization for diarrhea in U.S. Children. N Engl J Med. 2011;365(12):1108–17. doi:10.1056/NEJMoa1000446.
Gastañaduy P a, Curns AT, Parashar UD, Lopman B a. Gastroenteritis hospitalizations in older children and adults in the United States before and after implementation of infant rotavirus vaccination. JAMA. 2013;310(8):851–3. doi:10.1001/jama.2013.170800.
Lopman B. Global burden of norovirus and prospects for vaccine development.
Future directions for research on enterotoxigenic Escherichia coli vaccines for developing countries. Relev épidémiologique Hebd / Sect d’hygiène du Secrétariat la Société des Nations = Wkly Epidemiol Rec / Heal Sect Secr Leag Nations. 2006;81(11):97–104. http://www.ncbi.nlm.nih.gov/pubmed/16671213. Accessed 8 Jan 2016.
Ahmed T, Bhuiyan TR, Zaman K, Sinclair D, Qadri F. Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea. Cochrane Database Syst Rev. 2013;7(7), CD009029. doi:10.1002/14651858.CD009029.pub2.
Foodborne Diseases Active Surveillance Network (FoodNet). Emerg Infect Dis. 2012;3:581–583.
Muniesa M, Hammerl JA, Hertwig S, Appel B, Brüssow H. Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology. Appl Environ Microbiol. 2012;78(12):4065–73. doi:10.1128/AEM.00217-12.
CDC—Campylobacter, technical information—NCZVED. http://www.cdc.gov/nczved/divisions/dfbmd/diseases/Campylobacter/technical.html. Accessed 8 Jan 2016.
FoodNet 2012 Surveillance Report. http://www.cdc.gov/foodnet/PDFs/2012_annual_report_508c.pdf. Accessed 7 Jan 2016.
Epps SVR, Harvey RB, Hume ME, Phillips TD, Anderson RC, Nisbet DJ. Foodborne Campylobacter: Infections, metabolism, pathogenesis and reservoirs. Int J Environ Res Public Health. 2013;10(12):6292–304. doi:10.3390/ijerph10126292.
Incidence and trends of infection with pathogens transmitted commonly through food—Foodborne Diseases Active Surveillance Network, 10 U.S. sites, 1996–2012. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6215a2.htm. Accessed 6 Jan 2016.
Multistate Outbreak of Salmonella Poona Infections Linked to Imported Cucumbers | Multistate Outbreak of Salmonella Poona Infections Linked to Imported Cucumbers | September 2015 | Salmonella | CDC. http://www.cdc.gov/Salmonella/poona-09-15/. Accessed 8 Jan 2016.
Grass JE, Gould LH, Mahon BE. Epidemiology of foodborne disease outbreaks caused by Clostridium perfringens, United States, 1998–2010. Foodborne Pathog Dis. 2013;10(2):131–6. doi:10.1089/fpd.2012.1316.
Loharikar A, Newton AE, Stroika S, et al. Cholera in the United States, 2001–2011: a reflection of patterns of global epidemiology and travel. Epidemiol Infect. 2015;143(4):695–703. doi:10.1017/S0950268814001186.
Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379(9832):2151–61. doi:10.1016/S0140-6736(12)60560-1.
Chen WH, Greenberg RN, Pasetti MF, et al. Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, Prepared from new master and working cell banks. Clin Vaccine Immunol. 2014;21(1):66–73. doi:10.1128/CVI.00601-13.
Cholera | PaxVax—socially responsible vaccines. http://paxvax.com/cholera. Accessed 8 Jan 2016.
Collier SA, Stockman LJ, Hicks LA, Garrison LE, Zhou FJ, Beach MJ. Direct healthcare costs of selected diseases primarily or partially transmitted by water. Epidemiol Infect. 2012;140(11):2003–13. doi:10.1017/S0950268811002858.
Painter JE, Gargano JW, Collier SA, Yoder JS. Giardiasis surveillance—United States, 2011–2012. MMWR Surveill Summ. 2015;64 Suppl 3:15–25. http://www.ncbi.nlm.nih.gov/pubmed/25928582. Accessed 8 Jan 2016.
Painter JE, Gargano JW, Collier SA, Yoder JS. Morbidity and mortality weekly report (MMWR) Giardiasis Surveillance—United States , 2011 – 2012. 2015:2011–2012.
Buss BF, Joshi MV, O’Keefe AL, et al. Regional investigation of a cyclosporiasis outbreak linked to imported romaine lettuce—Nebraska and Iowa, June–August 2013. Epidemiol Infect. 2013;2015:1–11. doi:10.1017/S0950268815002484.
Outbreaks of cyclosporiasis—United States. MMWR Morb Mortal Wkly Rep. 2013;62(43):862. http://www.ncbi.nlm.nih.gov/pubmed/24172881. Accessed January 8, 2016.
Turkeltaub JA, McCarty TR, Hotez PJ. The intestinal protozoa: emerging impact on global health and development. Curr Opin Gastroenterol. 2015;31(1):38–44. doi:10.1097/MOG.0000000000000135.
Reddington K, Tuite N, Minogue E, Barry T. A current overview of commercially available nucleic acid diagnostics approaches to detect and identify human gastroenteritis pathogens. Biomol Detect Quantif. 2014;1(1):3–7. doi:10.1016/j.bdq.2014.07.001. Good review on current molecular panels.
Binnicker MJ. Multiplex molecular panels for the diagnosis of gastrointestinal infection: performance, result interpretation and cost-effectiveness. J Clin Microbiol. 2015. doi:10.1128/JCM.02103-15. Another good review on the utility and cost effectiveness of molecular panels.
Rand KH, Tremblay EE, Hoidal M, Fisher LB, Grau KR, Karst SM. Multiplex gastrointestinal pathogen panels: implications for infection control ☆. Diagn Microbiol Infect Dis. 2015;82(2):1–4. doi:10.1016/j.diagmicrobio.2015.01.007.
Goldenberg SD, Bacelar M, Brazier P, Bisnauthsing K, Edgeworth JD. A cost benefit analysis of the Luminex xTAG Gastrointestinal Pathogen Panel for detection of infectious gastroenteritis in hospitalised patients. J Infect. 2014;44(5):504–11. doi:10.1016/j.jinf.2014.11.009.
Baron EJ, Miller JM, Weinstein MP, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis. 2013;57(4):e22–121. doi:10.1093/cid/cit278. Good review on recommended work-up for small intestinal infections -- including commonly available tests and how to order them.
Thomson ABR, Chopra A, Clandinin MT, Freeman H. Recent advances in small bowel diseases: part I. World J Gastroenterol. 2012;18(26):3336–52. doi:10.3748/wjg.v18.i26.3336. Evaluates recent advances in basic sciences in small intestinal disease and their clinical application.
Thiagarajah JR, Donowitz M, Verkman AS. Secretory diarrhoea: mechanisms and emerging therapies. Nat Rev Gastroenterol Hepatol. 2015;12(8):446–57. doi:10.1038/nrgastro.2015.111. Good review on pathophysiology of infectious diarrhea and emerging therapies.
Lee KJ. Pharmacologic agents for chronic diarrhea. Intest Res. 2015;13(4):306–12. doi:10.5217/ir.2015.13.4.306.
Switaj TL, Winter KJ, Christensen SR. Diagnosis and management of foodborne illness. Am Fam Physician. 2015;92(5):358–365. http://www.ncbi.nlm.nih.gov/pubmed/26371569. Accessed 1 Feb 2016.
Ooi ST, Lorber B. Gastroenteritis due to Listeria monocytogenes. Clin Infect Dis. 2005;40(9):1327–32. doi:10.1086/429324.
Büla CJ, Bille J, Glauser MP. An epidemic of food-borne listeriosis in western Switzerland: description of 57 cases involving adults. Clin Infect Dis. 1995;20(1):66–72. http://www.ncbi.nlm.nih.gov/pubmed/7727673. Accessed 1 Feb 2016.
Bassily S, Farid Z, el-Masry NA, Mikhail EM. Treatment of intestinal E. histolytica and G. lamblia with metronidazole, tinidazole and ornidazole: a comparative study. J Trop Med Hyg. 1987;90(1):9–12. http://www.ncbi.nlm.nih.gov/pubmed/3546716. Accessed 1 Feb. 2016.
Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide. J Infect Dis. 2001;184(3):381–4. doi:10.1086/322038.
Amadi B, Mwiya M, Musuku J, et al. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet (Lond, Engl). 2002;360(9343):1375–80. doi:10.1016/S0140-6736(02)11401-2.
Fischer TK, Bresee JS, Glass RI. Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children. Vaccine. 2004;22 Suppl 1:S49–54. doi:10.1016/j.vaccine.2004.08.017.
Wikswo ME, Hall AJ. Outbreaks of acute gastroenteritis transmitted by person-to-person contact—United States, 2009–2010. MMWR Surveill Summ. 2012;61(9):1–12. http://www.ncbi.nlm.nih.gov/pubmed/23235338. Accessed 8 Jan 2016.
Kovaleva J, Peters FTM, van der Mei HC, Degener JE. Transmission of infection by flexible gastrointestinal endoscopy and bronchoscopy. Clin Microbiol Rev. 2013;26(2):231–54. doi:10.1128/CMR.00085-12.
Notes from the field: New Delhi metallo-β-lactamase-producing Escherichia coli associated with endoscopic retrograde cholangiopancreatography—Illinois, 2013. MMWR Morb Mortal Wkly Rep. 2014;62(51–52):1051. http://www.ncbi.nlm.nih.gov/pubmed/24381080. Accessed 8 Jan 2016.
Killeen S, Martin ST, Hyland J, O’ Connell PR, Winter DC. Clostridium difficile enteritis: a new role for an old foe. Surgery. 2014;12(5):256–62. doi:10.1016/j.surge.2014.01.008. Review on small intestinal C. difficile.
Steffen R, Hill DR, DuPont HL. Traveler’s diarrhea: a clinical review. JAMA. 2015;313(1):71–80. doi:10.1001/jama.2014.17006. A very good account of traveler’s diarrhea.
Zboromyrska Y, Hurtado JC, Salvador P, et al. Aetiology of traveller’s diarrhoea: evaluation of a multiplex PCR tool to detect different enteropathogens. Clin Microbiol Infect. 2014;20(10):O753–9. doi:10.1111/1469-0691.12621.
DuPont HL. Review article: the antimicrobial effects of rifaximin on the gut microbiota. Aliment Pharmacol Ther. 2016;43 Suppl 1:3–10. doi:10.1111/apt.13434.
Patel R, DuPont HL. New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. Clin Infect Dis. 2015;60 Suppl 2:S108–21. doi:10.1093/cid/civ177. Review on the current status of probiotics.
Cello JP, Day LW. Idiopathic AIDS enteropathy and treatment of gastrointestinal opportunistic pathogens. Gastroenterology. 2009;136(6):1952–65. doi:10.1053/j.gastro.2008.12.073. Good review of AIDS-related small intestinal infections.
Brenchley JM, Douek DC. HIV infection and the gastrointestinal immune system. Mucosal Immunol. 2008;1(1):23–30. doi:10.1038/mi.2007.1.
Krones E, Högenauer C. Diarrhea in the immunocompromised patient. Gastroenterol Clin N Am. 2012;41(3):677–701. doi:10.1016/j.gtc.2012.06.009. Good review on all-cause diarrhea in immunocompramised patients.
Lawlor G, Moss AC. Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander? Inflamm Bowel Dis. 2010;16(9):1620–7. doi:10.1002/ibd.21275.
Bhaijee F, Subramony C, Tang S-J, Pepper DJ. Human immunodeficiency virus-associated gastrointestinal disease: common endoscopic biopsy diagnoses. Pathol Res Int. 2011;2011:247923. doi:10.4061/2011/247923.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal studies performed by either of the authors.
Additional information
This article is part of the Topical Collection on Small Intestine
Rights and permissions
About this article
Cite this article
Munot, K., Kotler, D.P. Small Intestinal Infections. Curr Gastroenterol Rep 18, 31 (2016). https://doi.org/10.1007/s11894-016-0502-4
Published:
DOI: https://doi.org/10.1007/s11894-016-0502-4